With respect to rs299290 and ovarian cancer risk, no evidence of association was found under the single disease risk model or the competing risks model (p > 0.65; only breast cancer risk in BRCA1 mutation carriers was significant in this model: p = 2.5 x 10−4). Here, BRCA1 is linked to ovarian cancer.